AbbVie: a 5% pause after the run to the highs
AbbVie slips 5% off the highs, but the weekly trend holds firm
AbbVie: a 5% pause after the run to the highs
Our view last week
AbbVie is in week 5 of a buy signal, and the trade already sits at +19.91% since entry. All 3 price targets from our most advanced model have already been hit, but the management roadmap runs through week 10. The stop has moved to breakeven: risk is zeroed out, with the first trimming window one week away.
This week's summary
AbbVie shares give back 5% after their run toward the highs: this week's technical analysis shows the first signs of buyer fatigue, with buying dominance collapsing and sellers in control of the last session. The underlying structure still holds — aligned trend, rising ADX — and the trade, now in week 6, is already up 13.94% since entry.
IQS Phase
60
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#33 / 129
US stocks in progress
Trade P&L %
+13.94%
from signal to today
restricted Platinum content